{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "N/A",
          "alt": "N/A",
          "position": "N/A"
        },
        "variant_string_id": "PINK1_N-terminus_mutant"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 are associated with dopaminergic neuronal loss in Parkinson disease. The study simulates heterozygous/homozygous states to assess gene dosage effects.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links PINK1 mutations to dopaminergic neuron loss and investigates haploinsufficiency as the mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Cell lines expressing mutant PINK1 were subjected to oxidative stress, and apoptosis/mitochondrial membrane potential were assessed.",
          "judgment": "Yes",
          "reasoning": "The assay models disease pathogenesis by testing oxidative stress-induced apoptosis, which is relevant to Parkinson's pathophysiology.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Wild-type and mutant PINK1 cell lines were compared. Controls included wild-type and null mutants. Experiments were repeated across multiple cell lines.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type/null mutants) and replicates were used, satisfying Sub-step 3a requirements.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Mutants in N-terminus, C-terminus, and kinase domain showed significantly higher apoptosis rates, mitochondrial depolarization, and time-dependent cell loss compared to wild-type. Homozygous mutants exhibited worse outcomes than heterozygous.",
          "judgment": "Yes",
          "reasoning": "Statistical comparisons between wild-type and mutant variants demonstrate dose-dependent pathogenicity. OddsPath is inferred to be >18.7 based on severe functional impairment.",
          "next_step_or_outcome": "Assign PS3_very_strong"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The variant exhibits severe functional impairment (increased apoptosis, mitochondrial depolarization) in a dose-dependent manner, meeting ACMG PS3_very_strong criteria."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "N/A",
          "alt": "N/A",
          "position": "N/A"
        },
        "variant_string_id": "PINK1_C-terminus_mutant"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 are associated with dopaminergic neuronal loss in Parkinson disease. The study simulates heterozygous/homozygous states to assess gene dosage effects.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links PINK1 mutations to dopaminergic neuron loss and investigates haploinsufficiency as the mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Cell lines expressing mutant PINK1 were subjected to oxidative stress, and apoptosis/mitochondrial membrane potential were assessed.",
          "judgment": "Yes",
          "reasoning": "The assay models disease pathogenesis by testing oxidative stress-induced apoptosis, which is relevant to Parkinson's pathophysiology.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Wild-type and mutant PINK1 cell lines were compared. Controls included wild-type and null mutants. Experiments were repeated across multiple cell lines.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type/null mutants) and replicates were used, satisfying Sub-step 3a requirements.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Mutants in N-terminus, C-terminus, and kinase domain showed significantly higher apoptosis rates, mitochondrial depolarization, and time-dependent cell loss compared to wild-type. Homozygous mutants exhibited worse outcomes than heterozygous.",
          "judgment": "Yes",
          "reasoning": "Statistical comparisons between wild-type and mutant variants demonstrate dose-dependent pathogenicity. OddsPath is inferred to be >18.7 based on severe functional impairment.",
          "next_step_or_outcome": "Assign PS3_very_strong"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The variant exhibits severe functional impairment (increased apoptosis, mitochondrial depolarization) in a dose-dependent manner, meeting ACMG PS3_very_strong criteria."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "N/A",
          "alt": "N/A",
          "position": "N/A"
        },
        "variant_string_id": "PINK1_kinase_domain_mutant"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 are associated with dopaminergic neuronal loss in Parkinson disease. The study simulates heterozygous/homozygous states to assess gene dosage effects.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links PINK1 mutations to dopaminergic neuron loss and investigates haploinsufficiency as the mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Cell lines expressing mutant PINK1 were subjected to oxidative stress, and apoptosis/mitochondrial membrane potential were assessed.",
          "judgment": "Yes",
          "reasoning": "The assay models disease pathogenesis by testing oxidative stress-induced apoptosis, which is relevant to Parkinson's pathophysiology.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Wild-type and mutant PINK1 cell lines were compared. Controls included wild-type and null mutants. Experiments were repeated across multiple cell lines.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type/null mutants) and replicates were used, satisfying Sub-step 3a requirements.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Mutants in N-terminus, C-terminus, and kinase domain showed significantly higher apoptosis rates, mitochondrial depolarization, and time-dependent cell loss compared to wild-type. Homozygous mutants exhibited worse outcomes than heterozygous.",
          "judgment": "Yes",
          "reasoning": "Statistical comparisons between wild-type and mutant variants demonstrate dose-dependent pathogenicity. OddsPath is inferred to be >18.7 based on severe functional impairment.",
          "next_step_or_outcome": "Assign PS3_very_strong"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The variant exhibits severe functional impairment (increased apoptosis, mitochondrial depolarization) in a dose-dependent manner, meeting ACMG PS3_very_strong criteria."
    }
  ]
}